Camellia Regulatory News (CAM)

Camellia Information

Buy CAM Shares
Add CAM to Watchlist
Add CAM to Alert

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 4,540.00

Bid: 4,460.00

Ask: 4,580.00

Change: 70.00 (1.57%)

Spread: 120.00 (2.691%)

Open: 4,540.00

High: 4,540.00

Low: 4,500.00

Prev. Close: 4,450.00

Last checked at -

Interim Results

28 Aug 2008 15:29

RNS Number : 2325C

Camellia PLC

28 August 2008

Camellia Plc

Half-yearly report 2008

Highlights from the results
	Six months ended		Six months ended
	30 June 2008		30 June 2007

	£'000		£'000

Revenue	77,611		74,550

Trading profit/(loss)	2,837		(359)

Profit before tax	7,991		12,255

Profit for the period	6,073		10,965

Earnings per share	203.9	p	387.2	p

Interim dividend	20	p	20	p

Chairman's statement

The pre-tax profit from continuing operations of £7,991,000 for the six months to 30 June 2008 compares with a profit of £12,255,000 for the same period last year which included a profit of £5,313,000 on the disposal of 'available for sale' investments.

The board has declared an interim dividend of 20p per ordinary share payable on 6 November 2008 to share holders on the register on 17 October 2008.

Tea

India

Despite dry weather at the beginning of the year, crops are only marginally behind those of the previous year. Sales prices are ahead of last year particularly for orthodox teas produced in Assam and Darjeeling. The demand for independent statehood in Darjeeling and the possible associated civil unrest are a cause for concern.

Bangladesh

Tea production in Bangladesh is similar to the previous year but tea prices have increased. The prospects for the full year are encouraging.

Africa

Kenya experienced a major drought at the beginning of the year which has reduced production significantly when compared to the previous year. The cost of production has increased as a result of the lower crop but increased sales prices have compensated to some degree. The political difficulties that Kenya experienced at the beginning of the year have been resolved for the time being by the formation of a Government of National Unity, which must now negotiate a new constitution.

Our operations in Malawi have produced a crop similar to the previous year but higher sales prices have more than offset the increased cost of production.

Edible nuts

Macadamia production in both Malawi and South Africa is expected to exceed that of the previous year and prices have recently shown some improvement over the low levels of last year.

Crop projections for the harvest in September of our pistachio orchards in California are encouraging.

Other horticulture

Both production and sales prices for our citrus operations in California are higher than the previous year.

Exportable production of table grapes and citrus in Chile is on a par with last year.

Kakuzi's avocado production is expected to exceed the previous year but difficulties in the port of Mombasa are playing havoc with shipping schedules and significant insurance claims are anticipated. The situation in the port is chaotic and is seriously affecting all exports from Kenya that have no option but to use Mombasa. It is to be hoped that the Government will take immediate and firm action to rectify the problems and enable Kenya to compete effectively in world markets.

Rubber production in Bangladesh is on a par with last year although prices are expected to be a little lower.

Maize and Soya prices have increased over last year and, with similar production, the results of our Brazilian farming operations are most satisfactory.

Wine production in both South Africa and Chile increased over the previous year but the international wine market remains very competitive.

Food storage and distribution

The re-organisation costs incurred in 2007 are beginning to show a positive result and it is hoped that Associated Cold Stores and Transport will make a profit for the full year. Rationalisation continues in this sector and as a result there is now more likelihood of the market, which has been very difficult for a number of years, returning to stability and profitability.

Engineering

The difficulties of recruiting skilled operatives in some of our engineering companies continue and are having a detrimental effect on profitability. The price of steel and the availability of specialist metals combined with the impact of the fall in demand in the construction industry are also current concerns for our operations.

Banking

It is relevant to repeat that Duncan Lawrie has no exposure to sub-prime mortgages and their derivatives and indeed is benefiting from the current credit crisis due to its strong balance sheet and very conservative lending policies. The wealth management division does of course continue to suffer from lower fee income as a result of the decline in stock market values. Duncan Lawrie has now completed the integration of recent acquisitions, the costs of which will be a charge against profits in the current year.

Pharmaceutical

Net sales of Siegfried Holding AG were marginally ahead of the same period last year. Operating profit increased by 33% mainly as a result of the sale of the pharmaceutical production facility in Zofingen to the US-based Arena Pharmaceuticals and also to the receipt of licence payments for a previous bio-generic project.

Prospects

The Camellia Group is presently operating in a difficult global trading environment. The substantially increased costs of energy and fertilisers are a major cause of concern. However, the group's diversity and conservative policies, particularly in respect of borrowings, means that it should be well placed to withstand any forthcoming recession and continue to develop its operations in a modest and structured manner. It is however even more difficult than usual to give any indication of the outcome for the full year.

M C Perkins

Chairman

28 August 2008

Interim management report

The chairman's statement forms part of this report and includes important events that have occurred during the six months ended 30 June 2008 and their impact on the financial statements set out herein.

Principal risks and uncertainties

The directors' report in the statutory financial statements for the year ended 31 December 2007 (the accounts are available on the company's website: www.camellia.plc.uk) highlighted risks and uncertainties that could have an impact on the group's businesses. As these businesses are widely spread both in terms of activity and location, it is unlikely that any one single factor could have a material impact on the group's performance. These risks and uncertainties continue to be relevant for the remainder of the year. In addition, the chairman's statement included in this report refers to specific risks and uncertainties that the group is presently facing.

Statement of directors' responsibilities

The directors confirm that these condensed financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union, and that the interim management report herein includes a fair review of the information required by sections 4.2.7 and 4.2.8 of the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

The directors of Camellia Plc are listed in the Camellia Plc statutory financial statements for the year ended 31 December 2007. There have been no subsequent changes of directors and a list of current directors is maintained on the group's website at www.camellia.plc.uk.

By order of the board

M C PerkinsChairman 28 August 2008

Consolidated income statement
for the six months ended 30 June 2008

		Six months		Six months		Year
		ended		ended		ended
		30 June		30 June		31 December
		2008		2007		2007
	Notes	£'000		£'000		£'000

Revenue	4	77,611		74,550		161,936
Cost of sales		(53,683)		(53,828)		(107,497)
Gross profit		23,928		20,722		54,439
Other operating income		1,029		887		1,631
Distribution costs		(3,370)		(2,984)		(9,665)
Administrative expenses		(18,750)		(18,984)		(37,261)
Trading profit/(loss)	4	2,837		(359)		9,144
Share of associates' results	5	5,185		7,743		10,568
Profit on disposal of other investments	6	23		5,313		5,259
Profit on part disposal of a subsidiary	7	104		-		170
Profit on disposal of property		-		-		2,029
Profit on disposal of non-current
assets held for sale		-		171		327
Gain/(loss) arising from changes in
fair value of biological assets		178		(637)		2,770
Profit from operations		8,327		12,231		30,267
Investment income		476		457		867
Finance income		278		377		701
Finance costs		(1,218)		(1,107)		(1,921)
Pension schemes' net financing income		128		297		737
Net finance costs	8	(812)		(433)		(483)
Profit before tax		7,991		12,255		30,651
Taxation	9	(1,918)		(1,290)		(3,205)
Profit for the period		6,073		10,965		27,446

Profit attributable to minority interests		406		203		2,129
Profit attributable to equity shareholders		5,667		10,762		25,317
		6,073		10,965		27,446

Earnings per share - basic and diluted	11	203.9	p	387.2	p	910.8	p

Consolidated balance sheet
at 30 June 2008
		30 June		30 June		31 December
		2008		2007		2007
	Notes	£'000		£'000		£'000
Non-current assets
Intangible assets		8,376		7,767		8,246
Property, plant and equipment	12	75,885		76,117		76,233
Biological assets		79,797		76,047		80,633
Prepaid operating leases		1,013		985		982
Investments in associates		99,677		82,720		90,367
Deferred tax assets		4,152		272		1,356
Other investments		36,516		38,364		41,186
Retirement benefit surplus		3,618		8,566		5,766
Trade and other receivables		616		546		634
Total non-current assets		309,650		291,384		305,403
Current assets
Inventories		22,340		19,906		20,137
Trade and other receivables		71,313		59,143		67,893
Current income tax assets		1,623		2,164		1,616
Cash and cash equivalents	13	283,671		252,186		235,612
		378,947		333,399		325,258
Non-current assets classified as held for sale		-		105		-
Total current assets		378,947		333,504		325,258
Current liabilities
Borrowings	14	(16,875)		(16,935)		(14,771)
Trade and other payables		(324,162)		(286,152)		(275,913)
Current income tax liabilities		(2,176)		(1,455)		(1,786)
Other employee benefit obligations		(183)		(149)		(169)
Provisions		(75)		(37)		(123)
Total current liabilities		(343,471)		(304,728)		(292,762)
Net current assets		35,476		28,776		32,496
Total assets less current liabilities		345,126		320,160		337,899

Non-current liabilities
Borrowings	14	(11,348)		(12,297)		(11,797)
Deferred tax liabilities		(26,723)		(27,410)		(26,719)
Retirement benefit obligations		(17,367)		(10,261)		(10,608)
Other employee benefit obligations		(1,385)		(1,233)		(1,293)
Other non-current liabilities		(207)		(401)		(341)
Provisions		-		(92)		-
Total non-current liabilities		(57,030)		(51,694)		(50,758)
Net assets		288,096		268,466		287,141

Equity
Called up share capital		284		284		284
Reserves		267,483		249,407		265,987
Shareholders' funds	18	267,767		249,691		266,271
Minority interests	18	20,329		18,775		20,870
Total equity		288,096		268,466		287,141

Consolidated cash flow statement
for the six months ended 30 June 2008
		Six months		Six months		Year
		ended		ended		ended
		30 June		30 June		31 December
		2008		2007		2007
	Notes	£'000		£'000		£'000
Cash generated from operations
Cash flows from operating activities	16	(1,497)		1,831		14,171
Interest paid		(1,254)		(1,108)		(2,271)
Income taxes paid		(1,805)		(2,220)		(3,442)
Interest received		164		416		697
Dividends received from associates		2,397		1,955		2,252
Net cash flow from operating activities		(1,995)		874		11,407
Cash flows from investing activities
Purchase of intangible assets		(336)		(90)		(208)
Purchase of property, plant and equipment		(4,277)		(3,493)		(6,953)
Proceeds from sale of non-current assets		143		399		2,948
Proceeds from sale of non-current
assets held for sale		-		228		489
Part disposal of a subsidiary		297		-		400
Acquisition of subsidiary (net of cash acquired)		-		-		(549)
Purchase of minority interests		(173)		-		(193)
Purchase of shares in associate		-		-		(2)
Proceeds from sale of investments		6,735		7,269		8,235
Purchase of investments		(1,848)		(3,051)		(7,915)
Income from investments		476		457		867
Net cash flow from investing activities		1,017		1,719		(2,881)
Cash flows from financing activities
Equity dividends paid		-		-		(2,502)
Dividends paid to minority interests		(553)		(842)		(1,132)
Net repayment of debt		(1,560)		(3,734)		(3,625)
Net cash flow from financing activities		(2,113)		(4,576)		(7,259)
Net (decrease)/increase in cash and
cash equivalents	17	(3,091)		(1,983)		1,267
Cash and cash equivalents at beginning
of period		758		(542)		(542)
Exchange gains/(losses) on cash		412		(138)		33
Cash and cash equivalents at end
of period		(1,921)		(2,663)		758

For the purposes of the cash flow statement, cash and cash equivalents are included net of overdrafts repayable on demand. These overdrafts are excluded from the definition of cash and cash equivalents disclosed on the balance sheet.


For the purposes of the cash flow statement cash and cash equivalents comprise:
Cash and cash equivalents		283,671		252,186		235,612
Less banking operation funds		(271,691)		(240,820)		(223,849)
Overdrafts repayable on demand
(included in current liabilities - borrowings)		(13,901)		(14,029)		(11,005)
		(1,921)		(2,663)		758
Statement of recognised income and expense for the six months ended 30 June 2008

		Six months		Six months		Year
		ended		ended		ended
		30 June		30 June		31 December
		2008		2007		2007
		£'000		£'000		£'000

Foreign exchange translation differences		3,612		(1,887)		5,407
Actuarial movement on defined
benefit pension schemes (note 15)		(9,595)		11,516		6,030
Movement on deferred tax relating to
defined benefit pension schemes		2,686		(2,765)		(639)
Available-for-sale investments:
Valuation gains taken to equity		416		3,340		2,044
Transferred to profit or loss on sale		(2)		(3,676)		(3,630)
Share of associate's net movement in
defined benefit pension schemes		(1,246)		92		372
Share of associates' fair value adjustments		(748)		1,353		932
Share of associate's loss on cash flow hedges		-		(92)		(115)
Share of associate's income taxes on
items recorded in equity		466		-		(29)
Net (expense)/income recognised
directly in equity		(4,411)		7,881		10,372
Profit for the period		6,073		10,965		27,446
Total recognised income and expense
for the period		1,662		18,846		37,818
Attributable to:
Minority interests		91		314		2,505
Equity shareholders		1,571		18,532		35,313
		1,662		18,846		37,818
Notes to the accounts

1 Basis of preparation

These financial statements are the interim consolidated financial statements of Camellia Plc, a company registered in England, and its subsidiaries (the "group") for the six month period ended 30 June 2008 (the "Interim Report"). They should be read in conjunction with the Report and Accounts (the "Annual Report") for the year ended 31 December 2007.



The financial information contained in this interim report has not been audited and does not constitute statutory accounts within the meaning of Section 240 of the Companies Act 1985. A copy of the statutory accounts for the year ended 31 December 2007 has been delivered to the Registrar of Companies. The auditors' opinion on these accounts was unqualified and does not contain a statement made under Section 237(2) and Section 237(3) of the Companies Act 1985.




The interim financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") including IAS 34 "Interim Financial Reporting". For these purposes, IFRS comprise the Standards issued by the International Accounting Standards Board ("IASB") and Interpretations issued by the International Financial Reporting Interpretations Committee ("IFRIC") that have been endorsed by the European Union.




Where necessary, the comparatives have been reclassified from the previously reported interim results to take into account any presentational changes made in the Annual Report.

These interim financial statements were approved by the board of directors on 28 August 2008.

2 Accounting policies

These interim financial statements have been prepared on the basis of accounting policies consistent with those applied in the financial statements for the year ended 31 December 2007.


The following interpretations made by IFRIC are mandatory for the first time in the current financial year and have been adopted by the group with no significant impact on its consolidated results or financial position:

IFRIC 11 Group and treasury share transactions
IFRIC 12 Service concession arrangements
IFRIC 14 The limit on a defined benefit asset, minimum funding requirements and their interaction

3 Cyclical and seasonal factors

Due to climatic conditions the group's tea operations in India and Bangladesh produce most of their crop during the second half of the year. Tea production in Kenya remains at consistent levels throughout the year but in Malawi, the majority of tea is produced in the first six months.


Soya and maize in Brazil are generally harvested in the first half of the year. In California the pistachio crop occurs in the second half of the year and has 'on' and 'off' years. Avocados in Kenya are mostly harvested in the second half of the year.


There are no other cyclical or seasonal factors which have a material impact on the trading results.

4 Segment reporting

Six months ended

Year ended

30 June 2008

30 June 2007

31 December 2007

Revenue

Trading profit

Revenue

Trading profit

Revenue

Trading profit

£'000

Agriculture and horticulture

42,069

2,989

38,404

671

89,004

9,072

Engineering

10,132

671

10,293

947

20,109

2,124

Food storage and distribution

17,932

324

18,831

(356)

38,561

(133)

Banking and financial services

7,322

798

6,911

849

13,949

1,431

Other operations

156

111

(156)

313

(113)

77,611

4,838

74,550

1,955

161,936

12,381

Unallocated corporate expenses

(2,001)

(2,314)

(3,237)

Trading profit/(loss)

2,837

(359)

9,144

Share of associates' results

5,185

7,743

10,568

Profit on disposal of other

investments

5,313

5,259

Profit on part disposal of a

subsidiary

104

170

Profit on disposal of property

2,029

Profit on disposal of non-current

assets held for sale

171

327

Gain/(loss) arising from changes

in fair value of biological assets

178

(637)

2,770

Investment income

476

457

867

Net finance costs

(812)

(433)

(483)

Profit before tax

7,991

12,255

30,651

Taxation

(1,918)

(1,290)

(3,205)

Profit after tax

6,073

10,965

27,446

5 Share of associates' results

The group's share of the results of associates is analysed below:

Six months

Year

ended

30 June

31 December

2008

2007

£'000

Operating profit

6,579

4,914

8,561

Net finance costs

(463)

(90)

(650)

Profit before tax

6,116

4,824

7,911

Taxation

(931)

(701)

(1,026)

Profit after tax

5,185

4,123

6,885

Net profit from discontinued operations

3,620

3,683

5,185

7,743

10,568

The net profit from discontinued operations relates to the disposal by the Siegfried Group of its Sidroga division and its biologics business unit.

6 Profit on disposal of other investments

In 2007, a profit of £4,801,000 was realised on the disposal of the group's entire shareholding in Gétaz Romang Holding SA, a public quoted company on the SWX Swiss Exchange.

7 Profit on part disposal of a subsidiary

A profit of £104,000 (2007: six months £nil - year £170,000) was realised in relation to the disposal by Kakuzi Limited of 10% (2007: six months nil - year 14%) of its interest in Siret Tea Company Limited to EPK Outgrowers Empowerment Project Company Limited, a company mainly owned by smallholders in Kenya.

8 Finance income and costs

Six months

Year

ended

30 June

31 December

2008

2007

£'000

Interest payable on loans and bank overdrafts

(986)

(1,085)

(2,141)

Interest payable on obligations under finance

leases

(92)

(96)

(180)

Total borrowing costs

(1,078)

(1,181)

(2,321)

Net exchange (loss)/gain on foreign currency

borrowings

(140)

400

Finance costs

(1,218)

(1,107)

(1,921)

Finance income - interest income on short-term

bank deposits

278

377

701

Pension schemes' net financing income

128

297

737

Net finance costs

(812)

(433)

(483)

The above figures do not include any amounts relating to the banking subsidiaries.

9 Taxation on profit on ordinary activities

	Six months ended		Six months ended		Year ended
	30 June 2008		30 June 2007		31 December 2007
	£'000	£'000	£'000	£'000	£'000	£'000
Current tax
UK corporation tax	-		-		107
Overseas corporation tax	2,062		1,008		2,935
Total current tax		2,062		1,008		3,042

Deferred tax
Origination and reversal of timing differences
UK	529		(34)		(483)
Overseas	(673)		316		646
Total deferred tax		(144)		282		163
Tax on profit on ordinary activities		1,918		1,290		3,205
Tax on profit on ordinary activities for the six months to 30 June 2008 has been calculated on the basis of the estimated annual effective rate for the year ending 31 December 2008.

10 Equity dividends

Six months

Year

ended

30 June

31 December

2008

2007

£'000

Amounts recognised as distributions to equity holders in the period:

Final dividend for the year ended 31 December 2007

of 72.00p (2006: 70.00p) per share

2,001

1,946

Interim dividend for the year ended 31 December 2007

of 20.00p per share

556

2,502

Dividends amounting to £45,000 (2007: six months £44,000 - year £56,000) have not been included as group companies hold 62,500 issued shares in the company. These are classified as treasury shares.

Proposed interim dividend for the year ended 31

December 2008 of 20.00p (2007: 20.00p) per share

556

The proposed interim dividend was approved by the board of directors on 28 August 2008 and has not been included as a liability in these financial statements.

11 Earnings per share (EPS)

	Six months ended		Six months ended		Year ended
	30 June 2008		30 June 2007		31 December 2007
	Earnings	EPS	Earnings	EPS	Earnings	EPS
	£'000	Pence	£'000	Pence	£'000	Pence
Basic and diluted EPS
Attributable to ordinary shareholders	5,667	203.9	10,762	387.2	25,317	910.8

Basic and diluted earnings per share are calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares in issue of 2,779,500 (2007: six months 2,779,500 - year 2,779,500), which excludes 62,500 (2007: six months 62,500 - year 62,500) shares held by the group as treasury shares.

12 Property, plant and equipment

During the six months ended 30 June 2008 the group acquired assets with a cost of £4,277,000 (2007: six months £3,493,000 - year £6,953,000). Assets with a carrying amount of £96,000 were disposed of during the six months ended 30 June 2008 (2007: six months £217,000 - year £910,000).

13 Cash and cash equivalents

Included in cash and cash equivalents of £283,671,000 (2007: six months £252,186,000 - year £235,612,000) are cash and short-term funds, time deposits with banks and building societies and certificates of deposit amounting to £271,691,000 (2007: six months £240,820,000 - year £223,849,000), which are held by banking subsidiaries and which are an integral part of the banking operations of the group.

14 Borrowings

Borrowings (current and non-current) include loans and finance leases of £14,322,000 (2007: six months £15,203,000 - year £15,563,000) and bank overdrafts of £13,901,000 (2007: six months £14,029,000 - year £11,005,000). The following loans and finance leases were issued and repaid during the six months ended 30 June 2008:

£'000

Balance at 1 January 2008

15,563

Exchange differences

320

New issues

Loans

Finance lease liabilities

401

Repayments

Loans

(1,528)

Finance lease liabilities

(503)

Balance at 30 June 2008

14,322

15 Retirement benefit schemes

UK defined benefit pension schemes for the purposes of IAS 19 have been updated to 30 June 2008 from the valuations as at 31 December 2007 by the group's actuaries and the movements have been reflected in this interim statement. Overseas schemes have not been updated from 31 December 2007 valuations as it is considered that there have been no significant changes.

An actuarial loss of £13,471,000 was realised in the period in relation to the scheme assets following the recent falls in global stock markets. An actuarial gain of £3,876,000 was realised in relation to changes in the underlying actuarial assumptions. The assumed discount rate has increased to 6.70% (31 December 2007: 5.90%), giving rise to a decrease to the defined benefit obligation. This reduction is partly offset by the impact of increases in the assumptions for the rate of inflation, to 4.20% (31 December 2007: 3.40%), and for the rate of increases for salaries, to 4.30% (31 December 2007: 3.50%). There has been no change in the mortality assumptions used.


16 Reconciliation of profit from operations to cash flow
	Six months	Six months	Year
	ended	ended	ended
	30 June	30 June	31 December
	2008	2007	2007
	£'000	£'000	£'000

Profit from operations	8,327	12,231	30,267
Share of associates' results	(5,185)	(7,743)	(10,568)
Depreciation and amortisation	3,922	4,044	7,868
(Gain)/loss arising from changes in fair value
of biological assets	(178)	637	(2,770)
Profit on disposal of property, plant and equipment	(47)	-	(2,029)
Profit on disposal of non-current assets held for sale	-	(171)	(327)
Profit on part disposal of a subsidiary	(104)		(170)
Profit on disposal of other investments	(23)	(5,313)	(5,259)
Decrease/(increase) in working capital	907	(2,811)	(7,949)
Net (increase)/decrease in funds of banking
subsidiaries	(9,116)	957	5,108
Cash flows from operating activities	(1,497)	1,831	14,171

17 Reconciliation of net cash flow to movement in net debt

Six months

Year

ended

30 June

31 December

2008

2007

£'000

(Decrease)/increase in cash and cash

equivalents in the period

(3,091)

(1,983)

1,267

Cash outflow from decrease in debt

1,961

3,914

4,310

(Increase)/decrease in net debt resulting from

cash flows

(1,130)

1,931

5,577

New finance leases

(401)

(181)

(685)

Exchange rate movements

(116)

(197)

(Increase)/decrease in net debt in the period

(1,438)

1,634

4,695

Net debt at beginning of period

(14,805)

(19,500)

Net debt at end of period

(16,243)

(17,866)

(14,805)

18 Statement of changes in shareholders' equity

	Share	Share	Treasury	Retained	Other		Minority	Total
	capital	premium	shares	earnings	reserves	Total	interest	equity
	£'000	£'000	£'000	£'000	£'000	£'000	£'000	£'000

At 1 January 2007	284	15,298	(400)	182,543	38,236	235,961	19,303	255,264

Exchange differences	-	-	-	-	(1,998)	(1,998)	111	(1,887)
Net profit	-	-	-	10,762	-	10,762	203	10,965
Dividends	-	-	-	(1,946)	-	(1,946)	(842)	(2,788)
Actuarial gain	-	-	-	11,516	-	11,516	-	11,516
Deferred tax on actuarial gain	-	-	-	(2,765)	-	(2,765)	-	(2,765)
Available-for-sale investments:
Valuation gains taken to equity	-	-	-	-	3,340	3,340	-	3,340
Transfer to profit or loss on sale	-	-	-	-	(3,676)	(3,676)	-	(3,676)
Reclassification of investment to an
associate	-	-	-	-	(2,748)	(2,748)	-	(2,748)
Share of associates' fair value adjustments	-	-	-	1,353	-	1,353	-	1,353
Share of associate's change in treasury shares	-	-	-	144	-	144	-	144
Share of associate's movement in defined
benefit pension schemes	-	-	-	92	-	92	-	92
Share of associate's loss on cash flow hedges	-	-	-	(92)	-	(92)	-	(92)
Loss on dilution of interest in associate	-	-	-	(252)	-	(252)	-	(252)
At 30 June 2007	284	15,298	(400)	201,355	33,154	249,691	18,775	268,466

At 1 January 2007	284	15,298	(400)	182,543	38,236	235,961	19,303	255,264
Exchange differences	-	-	-	-	4,973	4,973	434	5,407
Net profit	-	-	-	25,317	-	25,317	2,129	27,446
Dividends	-	-	-	(2,502)	-	(2,502)	(1,132)	(3,634)
Actuarial gain	-	-	-	6,171	-	6,171	(141)	6,030
Deferred tax on actuarial gain	-	-	-	(684)	-	(684)	45	(639)
Available-for-sale investments:
Valuation gains taken to equity	-	-	-	-	2,006	2,006	38	2,044
Transfer to profit or loss on sale	-	-	-	-	(3,630)	(3,630)	-	(3,630)
Reclassification of investment to an
associate	-	-	-	-	(2,782)	(2,782)	-	(2,782)
Minority interest subscription	-	-	-	-	-	-	230	230
Payment to minority interest	-	-	-	-	-	-	(193)	(193)
Change in composition of group	-	-	-	(157)	-	(157)	157	-
Share of associates' fair value adjustments	-	-	-	932	-	932	-	932
Share of associate's loss on cash flow hedges	-	-	-	(115)	-	(115)	-	(115)
Share of associate's change in treasury shares	-	-	-	430	-	430	-	430
Share of associate's movement in defined
benefit pension schemes	-	-	-	372	-	372	-	372
Share of associate's income taxes on items
recorded in equity	-	-	-	(29)	-	(29)	-	(29)
Share of associates' other equity movements	-	-	-	123	-	123	-	123
Loss on dilution of interest in associate	-	-	-	(115)	-	(115)	-	(115)
At 31 December 2007	284	15,298	(400)	212,286	38,803	266,271	20,870	287,141

Exchange differences	-	-	-	-	3,927	3,927	(315)	3,612
Net profit	-	-	-	5,667	-	5,667	406	6,073
Dividends	-	-	-	(2,001)	-	(2,001)	(553)	(2,554)
Actuarial loss	-	-	-	(9,595)	-	(9,595)	-	(9,595)
Deferred tax on actuarial loss	-	-	-	2,686	-	2,686	-	2,686
Available-for-sale investments:
Valuation gains taken to equity	-	-	-	-	416	416	-	416
Transfer to profit or loss on sale	-	-	-	-	(2)	(2)	-	(2)
Minority interest subscription	-	-	-	-	-	-	192	192
Payment to minority interest	-	-	-	-	-	-	(173)	(173)
Change in composition of group	-	-	-	98	-	98	(98)	-
Share of associate's restatement of pension
plan assets	-	-	-	1,831	-	1,831	-	1,831
Share of associates' fair value adjustments	-	-	-	(748)	-	(748)	-	(748)
Share of associate's change in treasury shares	-	-	-	(62)	-	(62)	-	(62)
Share of associate's movement in defined
benefit pension schemes	-	-	-	(1,246)	-	(1,246)	-	(1,246)
Share of associate's income taxes on items
recorded in equity	-	-	-	466	-	466	-	466
Share of associate's other equity movements	-	-	-	150	-	150	-	150
Loss on dilution of interest in associate	-	-	-	(91)	-	(91)	-	(91)
At 30 June 2008	284	15,298	(400)	209,441	43,144	267,767	20,329	288,096


19 Related party transactions

There have been no related party transactions that have a material effect on the financial position or performance of the group in the first six months of the financial year.


20 Events after the balance sheet date

With effect from 1 July 2008, the group has representation on the board of West Hamilton Holdings Limited, a Bermudian property company, and as a result the investment in this company will be reclassified from a financial asset to an investment in associate. Based on the latest available accounts to 31 December 2007, the estimated result of this reclassification will be that the value of investments in associates will increase by £1,261,000, being the equity value, and the value of financial assets will decline by £2,696,000, being the market value. The difference of £1,435,000 will be transferred to reserves.

Further enquiries please contact Camellia Plc

Malcolm Perkins

01622 746655

28 August 2008

This information is provided by RNS

The company news service from the London Stock Exchange

END

IR KGGZRFRLGRZM

Date		Source	Headline
1st May 2024	12:30 pm	RNS	Annual Report & Notice of Annual General Meeting
29th Apr 2024	7:00 am	RNS	Final Results
25th Apr 2024	7:00 am	RNS	Director Changes
28th Mar 2024	12:11 pm	RNS	Update on BF&M disposal
4th Jan 2024	4:00 pm	RNS	Refocussing investments & Bardsley England update
27th Sep 2023	10:03 am	RNS	Trading Update
1st Sep 2023	5:21 pm	RNS	Interim Report 2023
1st Sep 2023	7:00 am	RNS	Half-year Report
17th Jul 2023	7:00 am	RNS	Director Changes
9th Jun 2023	12:08 pm	RNS	Result of AGM
8th Jun 2023	7:00 am	RNS	AGM Trading Statement
6th Jun 2023	12:00 pm	RNS	Sale of holding in BF&M Limited
11th May 2023	11:04 am	RNS	Annual Report and Notice of AGM
4th May 2023	7:00 am	RNS	Final Results
20th Mar 2023	7:00 am	RNS	Change of Registered Office Address
8th Mar 2023	7:00 am	RNS	Trading Update
30th Jan 2023	7:00 am	RNS	BF&M Strategic Review Conclusion
10th Jan 2023	9:01 am	RNS	Completion of Disposal of ACS&T
19th Dec 2022	7:00 am	RNS	Disposal of ACS&T and Relocation of Head Office
7th Dec 2022	7:00 am	RNS	Trading Update
22nd Nov 2022	2:38 pm	RNS	Trading Update
6th Sep 2022	2:45 pm	RNS	Interim Report 2022 - Replacement
1st Sep 2022	4:00 pm	RNS	Interim Report 2022
1st Sep 2022	7:00 am	RNS	Half-year Report
24th Aug 2022	7:00 am	RNS	Trading Update
1st Jul 2022	10:54 am	RNS	Results of Annual General Meeting - 30 June 2022
30th Jun 2022	7:00 am	RNS	BF&M Strategic Review
30th Jun 2022	7:00 am	RNS	AGM Trading Statement
9th Jun 2022	11:12 am	RNS	Board Committee Changes
6th Jun 2022	5:22 pm	RNS	Annual Report and Notice of AGM
31st May 2022	7:00 am	RNS	Final Results
6th May 2022	7:00 am	RNS	Director Changes and Trading Update
22nd Dec 2021	7:00 am	RNS	Trading Update
17th Nov 2021	7:00 am	RNS	100% Ownership of Bardsley England
2nd Nov 2021	7:00 am	RNS	Directorate Change
2nd Sep 2021	2:36 pm	RNS	Interim Report 2021
2nd Sep 2021	7:00 am	RNS	Half-year Report and changes to Board Committees
25th Aug 2021	12:42 pm	RNS	Notice of Interim Results
6th Aug 2021	8:30 am	RNS	Death of Director
5th Aug 2021	7:00 am	RNS	Sale of Abbey Metal Finishing
2nd Aug 2021	7:00 am	RNS	Purchase of Bardsley England
20th Jul 2021	2:00 pm	RNS	Trading Update
3rd Jun 2021	4:15 pm	RNS	Results of Annual General Meeting - 3 June 2021
3rd Jun 2021	12:00 pm	RNS	AGM Trading Statement
5th May 2021	4:00 pm	RNS	Annual Report and Notice of AGM
4th May 2021	7:00 am	RNS	Final Results and Directorate change
29th Apr 2021	4:30 pm	RNS	Final Results - Date of Announcement
11th Feb 2021	8:00 am	RNS	Trading update and settlement of claims
16th Nov 2020	7:00 am	RNS	Completion of asset disposal
2nd Nov 2020	7:15 am	RNS	Governance changes

Latest Share Chat

Camellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

Login to your account

Quickpicks are a member only feature

Login to your account